Loading clinical trials...
Loading clinical trials...
A Multi-Center, Open-label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener's Granulomatosis
Conditions
Interventions
Abatacept
Locations
4
United States
The Johns Hopkins Vasculitis Center
Baltimore, Maryland, United States
Boston University School of Medicine
Boston, Massachusetts, United States
Mayo Clinic College of Medicine
Rochester, Minnesota, United States
Cleveland Clinic
Cleveland, Ohio, United States
Start Date
February 1, 2008
Primary Completion Date
August 1, 2011
Completion Date
August 1, 2011
Last Updated
January 18, 2016
NCT02108860
NCT02115997
NCT01988506
NCT00104299
NCT01167491
NCT00307671
Lead Sponsor
University of Pennsylvania
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions